Lack of significant effects of Chlamydia trachomatis infection on cervical cancer risk in a nested case-control study in North-East Thailand

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 3, 2014, Pages 1497-1500

  Tungsrithong, Naowarat ^a   Kasinpila, Chananya ^a   Maneenin, Chanwit ^b   Namujju, Proscovia B ^c   Lehtinen, Matti ^c   Anttila, Ahti ^d   Promthet, Supannee ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UBON RATCHATHANI UNIVERSITY   (Thailand)

^c UNIVERSITY OF TAMPERE   (Finland)

^d FINNISH CANCER REGISTRY   (Finland)

Author keywords

Cervical cancer; Chlamydia infection; Nested case control study; Northeast thailand

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ARTICLE; BLOOD; CASE CONTROL STUDY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEMALE; HUMAN; IMMUNOLOGY; MICROBIOLOGY; RISK; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; THAILAND; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; RISK; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; THAILAND; UTERINE CERVICAL NEOPLASMS;

EID: 84896871904     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.3.1497     Document Type: Article

References (39)

1. Anttila T, Saikku P, Koskela P, et al (2001). Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA, 285, 47-51.
2. Arnheim Dahlström L, Andersson K, Luostarinen T, et al (2011). Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomarkers Prev, 20, 2541-50.
3. Au WW, Abdou-Salama S, Sierra-Torres CH, Al-Hendy A. (2007). Environmental risk factors for prevention and molecular intervention of cervical cancer. Int J Hyg Envir Hlth, 210, 671-8.
4. Bhatla N, Puri K, Joseph E, et al (2013). Association of Chlamydia trachomatis infection with human papillomavirus (HPV) and cervical intraepithelial neoplasia-a pilot study. Indian J Med Res, 137, 533-9.
5. Calil LN, Igansi CN, Meurer L, Edelweiss MI, Bozzetti MC (2011). Chlamydia trachomatis and human papillomavirus coinfection: association with p16INK4a and Ki67 expression in biopsies of patients with pre-neoplastic and neoplastic lesions. Braz J Infect Dis, 15, 126-31.
6. Castle PE, Escoffery C, Schachter J, et al (2003). Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients. Sex Transm Dis, 30, 575-80.
7. Chumduri C, Gurumurthy RK, Zadora PK, Mi Y, Meyer TF. (2013). Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host Microbe, 13, 746-58.
8. da Silva Barros NK, Costa MC, Alves RR, et al (2012). Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil. J Med Virol, 84, 1143-50.
9. de Abreu AL, Nogara PR, Souza RP, et al (2012). Molecular detection of HPV and Chlamydia trachomatis infections in Brazilian women with abnormal cervical cytology. Am J Trop Med Hyg, 87, 1149-51.
10. Deluca GD, Basiletti J, Schelover E, et al (2011). Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina. Braz J Infect Dis, 15, 567-72.
11. Farivar TN, Johari P (2012). Lack of association between Chlamydia trachomatis infection and cervical cancer-Taq Man realtime PCR assay findings. Asian Pac J Cancer Prev, 13, 3701-4.
12. Golijow CD, Abba MC, Mouron SA, et al (2005). Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol, 96, 181-6.
13. Insinga RP, Perez G, Wheeler CM, et al (2011). Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomarkers Prev, 20, 287-96.
14. Lazenby GB, Taylor PT, Badman BS, et al (2014). An association Between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening. Clin Ther, 36, 38-45.
15. Lehtinen M, Ault KA, Lyytikainen E, et al (2011). Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect, 87, 372-6.
16. Louie KS, de Sanjose S, Diaz M, et al. (2009) Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer, 100, 1191-7.
17. Luostarinen T, Namujju PB, Merikukka M, et al (2013). Order of HPV/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study. Int J Cancer, 133, 1756-9.
18. Madeleine MM, Anttila T, Schwartz SM, et al (2007). Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer, 120, 650-5.
19. Mendoza L, Mongelos P, Paez M, et al (2013). Human papillomavirus and other genital infections in indigenous women from Paraguay: a cross-sectional analytical study. BMC Infect Dis, 13, 531.
20. Moodley M, Moodley J, Chetty R, Herrington CS. (2003) The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int J Gynecol Cancer, 13, 103-10.
21. Moscicki AB, Hills N, Shiboski S, et al (2001). Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA, 285, 2995-3002.
22. Natphopsuk S, Settheetham-Ishida W, Pientong C, et al (2013). Human papillomavirus genotypes and cervical cancer in northeast Thailand. Asian Pac J Cancer Prev, 14, 6961-4.
23. Natphopsuk S, Settheetham-Ishida W, Sinawat S, et al (2012). Risk factors for cervical cancer in northeastern Thailand: detailed analyses of sexual and smoking behavior. Asian Pac J Cancer Prev, 13, 5489-95.
24. Naucler P, Chen H-C, Persson K, et al (2007). Seroprevalence of human papillomavirus and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol, 88, 814e22.
25. Onel M, Küçücük S, Töre G, Aǧaçfidan A (2013). Investigation of Chlamydia trachomatis seropositivity in patients with cervical cancer. Mikrobiyol Bul, 47, 702-7. (in Turkish).
26. Peitsidis P, Kalmantis K, Peitsidou A, et al (2012). Chlamydial infection in female lower genital tract and its correlation with cervical smear abnormalities. Bratisl Lek Listy, 113, 357-60.
27. Quint KD, de Koning MN, Geraets DT, Quint WG, Pirog EC (2009). Comprehensive analysis of human papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma. Gynecol Oncol, 114, 390-4.
28. Safaeian M, Quint K, Schiffman M, et al (2010). Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst, 102, 1794-804.
29. Seda J, Avellanet Y, Roca FJ, et al (2011). Risk factors for abnormal cervical cytology in pregnant women attending the high-risk obstetrics clinic at the University Hospital in San Juan, Puerto Rico. P R Health Sci J, 30, 14-7.
30. Settheetham-Ishida W, Yuenyao P, Tassaneeyakul W, et al (2006). Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand. Asian Pac J Cancer Prev, 7, 113-8.
31. Shew ML, Ermel AC, Weaver BA, et al (2013). Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance. J Infect Dis, 208, 1416-21.
32. Silins I, Ryd W, Strand A, et al (2005). Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer, 116, 110-5.
33. Silva J, Cerqueira F, Ribeiro J, et al., (2013). Is Chlamydia trachomatis related to human papillomavirus infection in young women of southern European population? A selfsampling study. Arch Gynecol Obstet, 288, 627-33.
34. Smith JS, Bosetti C, Munoz N, et al (2004). Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer, 111, 431-9.
35. Swangvaree SS, Kongkaew P, Ngamkham J (2013). Frequency and type-distribution of human papillomavirus from paraffinembedded blocks of high grade cervical intraepithelial neoplasia lesions in Thailand. Asian Pac J Cancer Prev, 14, 1023-6.
36. Tavares MC, de Macêdo JL, de Lima Júnior SF, et al (2014). Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil. Mol Biol Rep, 41, 865-74.
37. Wallin KL, Wiklund F, Luostarinen T, et al (2002). A populationbased prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer, 101, 371-4.
38. Yetimalar H, Kasap B, Cukurova K, et al (2011). Cofactors in human papillomavirus infection and cervical carcinogenesis. Arch Gynecol Obstet, 285, 805-10.
39. Zur Hausen H (1991). Human papillomaviruses in the pathogenesis of anogenital cancer. Virology, 184, 9-13.